Kemoterapiye Bağlı Tat Alma Değişikliği ve Hemşirelik Bakımı

Tat alma duyusu bireyin yaşamının devam ettirilmesinde görevli önemli bir duyudur. Tat alma duyusunun fonksiyonlarını olumsuz etkileyen pek çok faktör bulunmaktadır. Bu faktörler arasında kemoterapi ajanları da yer almaktadır. Kemoterapiye bağlı tat alma değişikliği hastaların sıklıkla yaşadıkları bir durumdur. Kemoterapi ajanlarının tat alma duyusundan sorumlu olan tat tomurcuklarını, tükürük salgısını etkilemesi ve nörotoksik etkileri nedeniyle kemoterapiye bağlı tat alma değişikliği ortaya çıkmaktadır. Alınan kemoterapi türü ve diğer değişkenlere göre hastaların yaşadıkları tat alma değişikliği farklılık göstermektedir. Yaşanılan tat alma değişikliği hastaları çok yönlü olarak etkilemekte ve yaşam kalitelerini azaltmaktadır. Bireylerin tat alma duyusunu değerlendirilmeli ve tat alma duyusunda meydana gelen değişiklere göre bakımları gerçekleştirilmelidir.

Anahtar Kelimeler:

Kemoterapi, Onkoloji Hemşireliği, Tat Alma Değişikliği

Chemotherapy Induced Taste Alteration and Nursing Care

The sense of taste is an important sense to maintain the life of an individual. There are many factors that negatively affect the function of the sense of taste. Chemotherapy agents are also included in these factors. Chemotherapy induced taste alteration is a condition commonly experienced by the patients. The taste alterations arise depending on chemotherapy due to the neurotoxic effects of chemotherapy agents and their effects on taste buds, which are responsible for the sense of taste, and the saliva. Taste alterations vary depending on the chemotherapy type received by patients and other variables. Taste alterations experienced by patients affect them in many ways and reduce the quality of their lives. Individuals’ sense of taste should be evaluated and they should receive treatments in accordance with changes occurred in their taste buds.

Keywords:

Chemoterapy, Oncology Nursing, Taste Alterations,

PDF

___

Boltong A, Keast R. The influence of chemotherapy on taste perception and food hedonics: A systematic review. Cancer Treat Rev 2012;38(2): 152–163.
Barret KE, Barman SM, Boitano S, Brooks HL. Ganong’un Tıbbi Fizyolojisi (Çev. Gökbel H, Okudan N, Gergerlioğlu HS, Belviranlı M.). İstanbul: Nobel Tıp Kitapevi 2011, 223-227.
Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 2001;9(8): 575–580.
Mann NM. Management of smell and taste problems. Cleve Clin J Med 2002;69(4): 329-336.
Mosel DD, Bauer RL, Lynch DP, Hwang ST. Oral complications in the treatment of cancer patients. Oral Dis 2011;17(6): 550–559.
Jensen S B, Mouridsen H T, Bergmann O J, Reibel J, Brünner N, Nauntofte B. Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106(2):217-226.
Hong JH, Omur-Ozbek P, Stanek BT, Dietrich AM, Duncan SE, Lee Y, et al. Taste and odor abnormalities in cancer patients. J Support Oncol 2009;7(2): 58-65.
Rehwaldt M, Wickham R, Purl S, Tariman J, Blendowski C, Shott S et al. Self-care strategies to cope with taste changes after chemotherapy. Oncol Nurs Forum 2009;36(2): 47–56.
Epstein J B, Phillips N, Parry J, Epstein M S, Nevill T, Stevenson Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002 ;30(11): 785-792.
Raber-Durlacher JE, Barasch A, Peterson DE, Lalla RV, Schubert MM, Fibbe WE. Oral complicationsand management considerations in patientstreatedwith high-dose chemotherapy. Supportive Cancer Ther 2004;1(4): 219-229.
Peregrin T. Improving taste sensation in patients who have undergone chemotherapyor radiation therapy. J Am Diet Assoc 2006;106(10): 1536-1540.
Boltong A, Keast R, Aranda S. Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment. Support Care Cancer 2012;20(11): 2765–2774.
Berteretche MV, Dalix AM, d'Ornano AM, Bellisle F, Khayat D, Faurion A. Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer 2004;12(8): 571–576.
Kano T, Kanda K. Development and validation of a chemotherapy induced taste alteration scale. Oncol Nurs Forum 2013;40(2): 79-85.
Fark T, Hummel C, Hähner A, Nin T, Hummel T. Characteristics of taste disorders. Eur Arch Otorhinolaryngol2013;270(6): 1855–1860.
Steinbach S, Hummel T, Bohner C, Berktold S, Hundt W, Kriner M et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast or gynecologic malignancies. J Clin Oncol 2009;27(11): 1899-1905.
Epstein J B, Barasch A. Taste disorders in cancer patients: Pathogenesis, and approach to assessment and management. Oral Oncol 2010;46(2): 77-81.
Camp-Sorrell D. Chemotherapy toxicities and management. In C. Yarbro, M. Frogge, and M. Goodman (Editor.). Sudbury, MA: Jones and Bartlett Publishers. Cancer Nursing 2005, 412-457.
Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS et al.. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 2010;18(8): 1081–1087.
Ravasco P. Aspects of taste and compliance in patients. Eur J Oncol Nurs 2005;9(2): 84-91.
Grant M, Kravits K. Symptoms and their ımpact on nutrition. Semin Oncol Nurs 2000;16(2): 113-121.
Sánchez-Lara K, Sosa-Sánchez R, Green-Renner D, Rodríguez C, Laviano A, Motola-Kuba D et al. Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 2010;9: 1-6.
Ishikawa T, Morita J, Kawachi K, Tagashira H. Incidence of dysgeusia associated with chemotherapy for cancer. Japanese Journal of Cancer and Chemotherapy 2013;40(8): 1049-1054.
Bernhardson BM, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 2008;16(3): 275–283.
Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao J J, Stineman MG et al. Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies. Support Care Cancer 2013;21(2): 549–555.
Müezzinoğlu, T. Yaşam kalitesi: Üroonkoloji derneği güz dönemi konuşması (2004).Web:http://www.uroonkoloji.org/ebulten/pdf/pdf_URO_128.pdf (Erişim tarihi: 18.05.2014).
Gamper EM, Giesinger JM, Oberguggenberger A, Kemmler G, Wintner LM, Gattringer K et al. Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlates. Acta Oncol 2012;51(4): 490–496.
Zaberningg A, Gamper EM, Giesinger JM, Rumpold G, Kemmler G, Gattringer K et al. Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?. Oncologist 2010;5(8): 913–920.
Imai H, Soeda H, Komine K, Otsuka K, Shibata H. Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer. BMC Palliat Care 2013;12(1):38.
Malaty J, Malaty IA. Smell and taste disorders in primary care. Am Fam Physician 2013;88(12): 852-859.
Berling K. Knutsson J, Rosenblad A, von Unge M. Evaluation of electrogustometry and the filter paper disc method for taste assessment. Acta Oto-Laryngologica 2011;131(5): 488–493.
Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. (June 2010). Web: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf (Erişim tarihi: 18 Mayıs 2014)
American Cancer Society. http://www.cancer.org/acs/groups/cid/documents/webcontent/002903-pdf.pdf
(Erişim tarihi: 10/01/2014)
National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/supportivecare/nutrition/HealthProfessional/page1/AllPages#Section_127 (Erişim tarihi: 10/01/2014)